Academic Review Statement

UMDNJ- Center for Continuing and Outreach Education has taken specific steps in the development of this activity and in the review of the educational content to ensure the information presented provides fair balance, and is accurate, timely, relevant, and based on the best available evidence.

Objectives

• Discuss data indicating that diabetes is a growing epidemic and is associated with increased risk of long-term comorbidities
• Identify specific barriers for patients and clinicians when attempting to meet recommended clinical goals for glycemic control
• Describe options for educating patients to achieve treatment goals

UMDNJ Liability Statement

The views expressed in this activity are those of the online attendees.
It should not be inferred or assumed that they are expressing the views of the University of Medicine and Dentistry of New Jersey, sanofi-aventis, U.S., or any other manufacturer of pharmaceuticals.
 
Participants are urged to consult the full prescribing information on any agents presented in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication.

Although this is a peer-reviewed educational Website, it does not offer continuing education (CE) credits.

sanofi-aventis Liability Statement

This website is supported by an unrestricted educational grant provided by sanofi-aventis US LLC.  Sanofi-aventis does not control operational aspects of this website, regularly review its content, nor monitor this site for the reporting of adverse events.

To report SUSPECTED ADVERSE REACTIONS, contact the FDA at 1-800-FDA-1088, or http://www.fda.gov.  Suspected adverse reactions that involve sanofi-aventis products can be reported to sanofi-aventis U.S. LLC at 1-800-633-1610 or to the FDA.

 

By clicking below, you certify that you have read and understood the information above.